FDx Advisors Inc. Raises Holdings in UnitedHealth Group Inc (UNH)
FDx Advisors Inc. raised its stake in UnitedHealth Group Inc (NYSE:UNH) by 9.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 42,165 shares of the healthcare conglomerate’s stock after purchasing an additional 3,697 shares during the period. FDx Advisors Inc.’s holdings in UnitedHealth Group were worth $11,218,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. White Lighthouse Investment Management Inc. bought a new stake in UnitedHealth Group in the 2nd quarter valued at $324,000. Wells Fargo & Company MN raised its stake in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock valued at $1,887,377,000 after buying an additional 39,480 shares in the last quarter. Sawtooth Solutions LLC raised its stake in shares of UnitedHealth Group by 34.4% in the 3rd quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock valued at $1,174,000 after buying an additional 1,129 shares in the last quarter. AXA raised its stake in shares of UnitedHealth Group by 5.7% in the 3rd quarter. AXA now owns 911,581 shares of the healthcare conglomerate’s stock valued at $242,517,000 after buying an additional 49,227 shares in the last quarter. Finally, HL Financial Services LLC raised its stake in shares of UnitedHealth Group by 15.3% in the 3rd quarter. HL Financial Services LLC now owns 17,183 shares of the healthcare conglomerate’s stock valued at $4,572,000 after buying an additional 2,281 shares in the last quarter. 85.57% of the stock is owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group stock opened at $276.85 on Friday. The stock has a market cap of $267.97 billion, a P/E ratio of 27.49, a PEG ratio of 1.60 and a beta of 0.76. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. UnitedHealth Group Inc has a 12-month low of $208.48 and a 12-month high of $287.94.
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.75%.
UNH has been the subject of a number of recent research reports. Citigroup cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price objective for the company. in a research note on Monday, September 10th. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 18th. Raymond James increased their price objective on shares of UnitedHealth Group from $285.00 to $304.00 and gave the company a “strong-buy” rating in a research note on Monday, September 24th. Bank of America increased their price objective on shares of UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a research note on Wednesday, October 17th. Finally, Morgan Stanley increased their price objective on shares of UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research note on Wednesday, September 5th. Two investment analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $292.48.
In related news, Director Richard T. Burke sold 20,000 shares of the stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total transaction of $5,268,200.00. Following the completion of the sale, the director now owns 1,720,112 shares in the company, valued at approximately $453,094,701.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Steven H. Nelson sold 8,142 shares of the stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the sale, the chief executive officer now owns 22,496 shares of the company’s stock, valued at approximately $5,961,440. The disclosure for this sale can be found here. Insiders have sold a total of 34,395 shares of company stock valued at $9,186,302 in the last quarter. 0.87% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Reverse Stock Split
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.